Tracker ID CR-R10
Neuralink: 21 trial participants; "zero serious device-related adverse events" so far.
ReferenceCompany-reported
- Claim made
- Who
- Neuralink
- Target date
- No target date set
- Status checked
- 28 September 2026
Source
Evidence to date
Company measurement; no independent or regulatory data checked.
Next indicator
Independent or regulatory safety data
Where this claim appears
Found this useful? Save it to your basket.